SCHEMBL27746396

SCHEMBL27746396

CC(=O)CC1c2c(F)cccc2C(=O)N1Cc1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HCRTR2 O43614 2/20 0.39
CASP3 P42574 1/20 0.39
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
UBE2N P61088 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TSHR P16473 1/20 0.38
HCRTR1 O43613 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2643582 0.83 MAPT (0.40) ALDH1A1MAPTKDM4ECYP1A2CYP3A4
SCHEMBL2644689 0.82 MAPT (0.43) ALDH1A1MAPTKDM4ECYP1A2CYP3A4
SCHEMBL2664954 0.81 CASP3 (0.39) ALDH1A1MAPTKDM4ECYP1A2CYP3A4
SCHEMBL2664915 0.81 CASP3 (0.39) ALDH1A1MAPTKDM4ECYP1A2CYP3A4
SCHEMBL2644694 0.81 MAPT (0.39) ALDH1A1MAPTKDM4ECYP1A2CYP3A4
SCHEMBL15926258 0.74 MAPT (0.36) ALDH1A1MAPTKDM4ECYP1A2CYP3A4
SCHEMBL2644105 0.74 MAPT (0.46) ALDH1A1MAPTKDM4ECYP1A2CYP3A4
SCHEMBL2644875 0.74 SMN1; SMN2 (0.47) ALDH1A1MAPTKDM4ELMNAL3MBTL1
SCHEMBL2644355 0.73 PARP1 (0.37) ALDH1A1MAPTKDM4EATMTSHR
SCHEMBL2643618 0.73 MAPT (0.40) ALDH1A1MAPTKDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101316836-A Substituted dihydroisoindolones as allosteric modulators of glucokinase JANSSEN PHARMACEUTICA NV (BE) 2008-12-03 CN disclosed